| Literature DB >> 34007227 |
Jia-Yu Zhang1,2, Jia Huang2, Su-Ya Zhao3, Xin Liu4, Zhen-Cheng Xiong5, Zhi-Ying Yang1,2.
Abstract
AIM: In order to find the risk factors of postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD) according to the latest definition and grading system of International Study Group of Pancreatic Surgery (ISGPS) (version 2016) and propose a nomogram for predicting POPF.Entities:
Keywords: International Study Group of Pancreatic Surgery; pancreatic fistula; pancreaticoduodenectomy; prediction model
Year: 2021 PMID: 34007227 PMCID: PMC8121671 DOI: 10.2147/RMHP.S305332
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
Disease Composition
| Pathological Type | N |
|---|---|
| Bile duct cancer | 46(19.83%) |
| Gallbladder cancer | 5(2.16%) |
| Choledochal cyst | 1(0.43%) |
| Retroperitoneal neoplasm (Lymphoma) | 1(0.43%) |
| Retroperitoneal neoplasm (Sarcoma) | 1(0.43%) |
| Periampullary cancer | 59(25.43%) |
| Chronic pancreatitis | 7(3.02%) |
| Duodenal cancer | 15(6.47%) |
| Duodenal stromal tumor | 4(1.72%) |
| Benign duodenal tumor | 2(0.86%) |
| Duodenal neuroendocrine tumor | 1(0.43%) |
| Gastric cancer | 2(0.86%) |
| Pancreatic ductal adenocarcinoma | 70(30.17%) |
| Pancreatic serous cystadenoma | 2(0.86%) |
| Pancreatic neuroendocrine tumor (G1) | 1(0.43%) |
| Pancreatic neuroendocrine tumor (G2) | 6(2.59%) |
| Pancreatic neuroendocrine tumor (G3) | 2(0.86%) |
| Pancreatic schwannoma | 1(0.43%) |
| Metastatic cancer | 2(0.86%) |
| IgG4-related disease | 2(0.86%) |
| Intraductal papillary mucinous neoplasm | 2(0.86%) |
| Total | 232 |
Risk Factors for Postoperative Pancreatic Fistula According to Univariate Analysis
| Variable | Pancreatic Fistula | |||
|---|---|---|---|---|
| No | Yes | P value | ||
| Sex | 0.070 | 0.792 | ||
| Male | 136(63.55%) | 12(66.67%) | ||
| Female | 78(36.45%) | 6(33.33%) | ||
| Age (yr) | 0.984 | 0.321 | ||
| ≥ 65 | 93(43.46%) | 10(55.56%) | ||
| < 65 | 121(56.54%) | 8(44.44%) | ||
| BMI (kg/m2) | 23.09±3.30 | 24.16±2.75 | 0.182 | |
| Hypertension | 3.836 | 0.050 | ||
| Yes | 70(32.71%) | 10(55.56%) | ||
| No | 144(67.29%) | 8(44.44%) | ||
| Drinking history | 0.952 | 0.329 | ||
| Yes | 60(28.04%) | 7(38.89%) | ||
| No | 154(71.96%) | 11(61.11%) | ||
| Pancreatitis history | 0.111 | 0.739 | ||
| Yes | 10(4.67%) | 0(0.00%) | ||
| No | 204(95.33%) | 18(100.00%) | ||
| Diabetes mellitus | 1.435 | 0.209 | ||
| Yes | 43(20.09%) | 1(5.56%) | ||
| No | 171(79.91%) | 17(94.44%) | ||
| Complication | 0.021 | 0.884 | ||
| Yes | 139(64.95%) | 12(66.67%) | ||
| No | 75(35.05%) | 6(33.33%) | ||
| Infectious disease | 0.001 | 0.648 | ||
| Yes | 17(7.94%) | 2(11.11%) | ||
| No | 197(92.06%) | 16(88.89%) | ||
| History of abdominal surgery | 1.622 | 0.135 | ||
| Yes | 45(21.03%) | 1(5.56%) | ||
| No | 169(78.97%) | 17(94.44%) | ||
| Preoperative biliary drainage | 0.352 | 0.553 | ||
| Yes | 80(37.38%) | 8(44.44%) | ||
| No | 134(62.62%) | 10(55.56%) | ||
| WBC(/L) | 0.141 | 0.435 | ||
| ≤ 10*109 | 191(89.25%) | 15(83.33%) | ||
| > 10*109 | 23(10.75%) | 3(16.67%) | ||
| Neutrophil ratio | 0.600 | 0.438 | ||
| ≤ 70% | 135(63.08%) | 13(72.22%) | ||
| > 70% | 79(36.92%) | 5(27.78%) | ||
| HGB(g/L) | 0.513 | 0.474 | ||
| ≥ 120 | 112(52.34%) | 11(61.11%) | ||
| < 120 | 102(47.66%) | 7(38.89%) | ||
| PLT(/L) | 0.128 | 0.278 | ||
| ≥ 100*109 | 211(98.60%) | 17(94.44%) | ||
| < 100*109 | 3(1.40%) | 1()5.56% | ||
| Preoperative total bilirubin (µmol/L) | 0.065 | 0.785 | ||
| ≤ 171 | 154(71.96%) | 14(77.78%) | ||
| > 171 | 60(28.04%) | 4(22.22%) | ||
| Serum albumin (g/L) | 0.137 | 0.551 | ||
| ≥ 35 | 169(78.97%) | 13(72.22%) | ||
| < 35 | 45(21.03%) | 5(27.78%) | ||
| Scr (µmol/L) | 66.65±24.64 | 71.53±12.88 | 0.407 | |
| Pylorus-preserving | <0.001 | 1.000 | ||
| Yes | 28(13.08%) | 2(11.11%) | ||
| No | 186(86.92%) | 16(88.89%) | ||
| Operative time (min) | 0.576 | 0.448 | ||
| ≤ 300 | 115(53.74%) | 8(44.44%) | ||
| > 300 | 99(46.26%) | 10(55.56%) | ||
| Blood loss (mL) | 0.069 | 0.793 | ||
| > 500 | 112(52.34%) | 10(55.56%) | ||
| ≤ 500 | 102(47.66%) | 8(44.44%) | ||
| Intraoperative red blood cell transfusion | 0.023 | 0.879 | ||
| No | 111(51.87%) | 9(50.00%) | ||
| Yes | 103(48.13%) | 9(50.00%) | ||
| Intraoperative plasma transfusion | 0.076 | 0.783 | ||
| No | 126(58.88%) | 10(55.56%) | ||
| Yes | 88(41.12%) | 8(44.44%) | ||
| Drainage of pancreatic duct stent | <0.001 | 1.000 | ||
| Yes | 178(83.18%) | 15(83.33%) | ||
| No | 36(16.82%) | 3(16.67%) | ||
| Pancreatic texture | 38.590 | <0.001 | ||
| Soft | 31(14.49%) | 14(77.78%) | ||
| Hard | 183(85.51%) | 4(22.22%) | ||
| Gastrojejunostomy | 2.424 | 0.096 | ||
| Retrocolic | 180(84.11%) | 12(66.67%) | ||
| Antecolic | 34(15.89%) | 6(33.33%) | ||
| Jejunostomy | 0.111 | 0.739 | ||
| Yes | 204(95.33%) | 18(100.00%) | ||
| No | 10(4.67%) | 0(0.00%) | ||
| Vascular resection | 1.298 | 0.231 | ||
| Yes | 25(11.68%) | 0(0.00%) | ||
| No | 189(88.32%) | 18(100.00%) | ||
Logistic Regression for the Predictors of Postoperative Pancreatic Fistula After Pancreaticoduodenectomy
| Variable | B | SE | P value | OR | 95% CI |
|---|---|---|---|---|---|
| Hypertension | 1.250 | 0.637 | 0.050 | 3.492 | 1.002–12.168 |
| Non-diabetes | 3.409 | 1.405 | 0.015 | 30.235 | 1.924–475.097 |
| No history of abdominal surgery | 2.326 | 1.153 | 0.044 | 10.237 | 1.068–98.071 |
| Soft pancreas | 3.805 | 0.780 | <0.001 | 44.931 | 9.745–207.161 |
| Antecolic gastrojejunostomy | 2.156 | 0.813 | 0.008 | 8.632 | 1.754–42.486 |
Figure 1Nomogram calculator in prediction for postoperative pancreatic fistula after pancreaticoduodenectomy.